• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌伴肝转移1例罕见病例

A Rare Case of Differentiated Thyroid Carcinoma with Liver Metastases.

作者信息

Topuz Özge Vural, Erhan Selma Sengiz, Erinç Sadife Rüya, Tamam Müge Öner

机构信息

Department of Nuclear Medicine, Prof Dr Cemil Tascioglu City Hospital, Istanbul, Turkey.

Department of Pathology, Prof Dr Cemil Tascioglu City Hospital, Istanbul, Turkey.

出版信息

Indian J Nucl Med. 2022 Apr-Jun;37(2):186-188. doi: 10.4103/ijnm.ijnm_152_21. Epub 2022 Jul 8.

DOI:10.4103/ijnm.ijnm_152_21
PMID:35982810
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9380802/
Abstract

Papillary thyroid carcinoma (PTC) is the most frequent type of differentiated thyroid cancers (DTCs) and commonly metastasizes to regional lymph nodes. Distant metastases of DTC typically occur in the lungs and bones. Liver metastases of DTC are very rare and difficult to diagnose. We present a case of a 52-year-old woman who had a previous history of PTC treated by total thyroidectomy and lymph node dissection. The patient received two radioactive iodine-131 (I-131) treatments. The second postradioiodine therapy whole-body scan (WBS) revealed intense iodine uptake in the neck region and in the lungs. After 2 months, during the follow-up period, increase in serum thyroglobulin (Tg) level was detected. Positron-emission tomography-computed tomography (PET-CT) with 18F-fluorodeoxyglucose (FDG) revealed increased FDG uptake in the mass lesion that invaded the muscles in the neck area, lung, bone, and liver. The uptake in liver was interpreted as suspicion of malignancy. The trucut biopsy of the liver masses demonstrated metastases of the thyroid carcinoma with the immunohistochemical thyroid transcription factor-1 and PAX8 positivity observed in these tumor cells. In DTC patients with progressive rapid rise of Tg level, the diagnostic value of I-131 WBS will decrease as the differentiation of the tumor decreases. The combined use of I-131 WBS and FDG PET-CT as diagnostic modalities in these patients will be important in treatment planning in detecting locoregional or distant metastases, especially in patients with negative diagnostic I-131 WBS.

摘要

乳头状甲状腺癌(PTC)是分化型甲状腺癌(DTC)中最常见的类型,通常转移至区域淋巴结。DTC的远处转移通常发生在肺和骨。DTC的肝转移非常罕见且难以诊断。我们报告一例52岁女性,既往有PTC病史,接受了全甲状腺切除术和淋巴结清扫术。该患者接受了两次放射性碘-131(I-131)治疗。第二次碘治疗后全身扫描(WBS)显示颈部区域和肺部有强烈的碘摄取。2个月后,在随访期间,检测到血清甲状腺球蛋白(Tg)水平升高。18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描-计算机断层扫描(PET-CT)显示,侵犯颈部肌肉、肺、骨和肝脏的肿块病变中FDG摄取增加。肝脏中的摄取被解释为怀疑恶性肿瘤。肝脏肿块的粗针活检显示甲状腺癌转移,在这些肿瘤细胞中观察到免疫组化甲状腺转录因子-1和PAX8阳性。在Tg水平进行性快速升高的DTC患者中,随着肿瘤分化程度降低,I-131 WBS的诊断价值也会降低。在这些患者中,联合使用I-131 WBS和FDG PET-CT作为诊断方法对于检测局部或远处转移的治疗计划很重要,尤其是对于I-131 WBS诊断为阴性的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/9380802/447ba3e90aea/IJNM-37-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/9380802/6ba5e3805226/IJNM-37-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/9380802/447ba3e90aea/IJNM-37-186-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/9380802/6ba5e3805226/IJNM-37-186-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f485/9380802/447ba3e90aea/IJNM-37-186-g002.jpg

相似文献

1
A Rare Case of Differentiated Thyroid Carcinoma with Liver Metastases.分化型甲状腺癌伴肝转移1例罕见病例
Indian J Nucl Med. 2022 Apr-Jun;37(2):186-188. doi: 10.4103/ijnm.ijnm_152_21. Epub 2022 Jul 8.
2
Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.碘-131单光子发射计算机断层扫描/计算机断层扫描(SPET/CT)和18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(18F-FDG PET/CT)用于鉴别和定位分化型甲状腺癌的纵隔淋巴结转移灶。
Hell J Nucl Med. 2013 Sep-Dec;16(3):199-203.
3
Comparative Uptake Patterns of Radioactive Iodine and [18F]-Fluorodeoxyglucose (FDG) in Metastatic Differentiated Thyroid Cancers.放射性碘与[18F]-氟脱氧葡萄糖(FDG)在转移性分化型甲状腺癌中的摄取模式比较
J Clin Med. 2024 Jul 6;13(13):3963. doi: 10.3390/jcm13133963.
4
Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels.放射性碘治疗后应用 18 氟-脱氧葡萄糖正电子发射断层扫描在甲状腺球蛋白升高的分化型甲状腺癌中的应用。
Thyroid. 2012 Aug;22(8):832-8. doi: 10.1089/thy.2012.0081.
5
Diagnostic Capabilities of MRI Versus 18F FDG PET-CT in Postoperative Patients with Thyroglobulin Positive, 131I-negative Local Recurrent or Metastatic Thyroid Cancer.MRI与18F FDG PET-CT对甲状腺球蛋白阳性、131I阴性的局部复发或转移性甲状腺癌术后患者的诊断能力
Curr Med Imaging Rev. 2019;15(10):956-964. doi: 10.2174/1573405614666180718124739.
6
Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.放射性碘全身扫描、甲状腺球蛋白水平、99mTc-MIBI扫描及计算机断层扫描:分化型甲状腺癌肺转移患者的结果
Nucl Med Commun. 2006 Mar;27(3):261-6. doi: 10.1097/00006231-200603000-00009.
7
Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对复发性乳头状甲状腺癌患者的预后影响
Head Neck. 2018 Jan;40(1):94-102. doi: 10.1002/hed.24967. Epub 2017 Nov 11.
8
Fluorodeoxyglucose PET/CT in patients with differentiated thyroid cancer and elevated thyroglobulin after total thyroidectomy and (131)I ablation.全甲状腺切除及(131)I 消融术后分化型甲状腺癌且甲状腺球蛋白升高患者的氟脱氧葡萄糖 PET/CT 检查
Q J Nucl Med Mol Imaging. 2008 Mar;52(1):2-8.
9
Complementary role of 18F-fluorodeoxyglucose positron emission tomography and 131I scan in the follow-up of post-therapy differentiated thyroid cancer.18F-氟脱氧葡萄糖正电子发射断层扫描与131I扫描在分化型甲状腺癌治疗后随访中的互补作用
J Formos Med Assoc. 2002 Jul;101(7):459-67.
10
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose.分化型甲状腺癌患者的术后诊断评估:超声、碘-131闪烁扫描及氟-18氟脱氧葡萄糖PET的比较
Radiol Med. 2008 Mar;113(2):278-88. doi: 10.1007/s11547-008-0243-z. Epub 2008 Apr 2.

本文引用的文献

1
Clinical Status and Treatment of Liver Metastasis of Differentiated Thyroid Cancer Using Tyrosine Kinase Inhibitors.使用酪氨酸激酶抑制剂治疗分化型甲状腺癌肝转移的临床状况
World J Surg. 2018 Nov;42(11):3632-3637. doi: 10.1007/s00268-018-4676-9.
2
LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES.分化型甲状腺癌伴远处转移患者的长期预后及预后因素
Endocr Pract. 2017 Oct;23(10):1193-1200. doi: 10.4158/EP171924.OR. Epub 2017 Jul 13.
3
Liver resection for non-colorectal, non-endocrine liver metastasis.
非结直肠癌、非内分泌性肝转移瘤的肝切除术
Pol Przegl Chir. 2015 Feb 3;86(11):544-51. doi: 10.2478/pjs-2014-0097.
4
Uncommon metastases from differentiated thyroid carcinoma.分化型甲状腺癌的罕见转移
Hell J Nucl Med. 2012 Sep-Dec;15(3):233-40. doi: 10.1967/s002449910059. Epub 2012 Oct 25.
5
Rare metastases of differentiated thyroid carcinoma: pictorial review.分化型甲状腺癌的罕见转移:影像学综述。
Endocr Relat Cancer. 2011 Aug 30;18(5):R165-74. doi: 10.1530/ERC-11-0068. Print 2011 Oct.
6
Prognostic factors and therapeutic strategies for differentiated carcinomas of the thyroid.甲状腺分化型癌的预后因素及治疗策略
Endocr J. 2009;56(2):177-92. doi: 10.1507/endocrj.k08e-166. Epub 2008 Aug 13.
7
Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis.分化型甲状腺癌的预期寿命:一种生存分析的新方法。
Endocr Relat Cancer. 2005 Jun;12(2):273-80. doi: 10.1677/erc.1.00892.
8
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levels.[18F]-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描可在诊断性(131)I全身扫描阴性且血清甲状腺球蛋白水平升高的患者中定位残留甲状腺癌。
J Clin Endocrinol Metab. 1999 Jul;84(7):2291-302. doi: 10.1210/jcem.84.7.5827.
9
Metastasis to the liver in well-differentiated carcinoma of the thyroid.甲状腺高分化癌的肝转移
Thyroid. 1996 Dec;6(6):607-11. doi: 10.1089/thy.1996.6.607.